Late hemorrhagic disease of newborn

I E D'Souza1, S D Subba Rao

  • 1Department of Pediatrics, St. John's Medical College Hospital, Bangalore, Karnataka, India.

Indian Pediatrics
|March 27, 2003
PubMed

Insights

Late hemorrhagic disease of the newborn (LHDN) severely affects exclusively breast-fed infants. Vitamin K prophylaxis is crucial for preventing this serious condition and its potentially fatal outcomes.

Area of Science:

  • Neonatology
  • Pediatric Hematology
  • Public Health

Background:

  • Late hemorrhagic disease of the newborn (LHDN) is a serious bleeding disorder in infants.
  • Exclusively breast-fed infants are particularly vulnerable.
  • Vitamin K deficiency is a primary cause of LHDN.

Purpose of the Study:

  • To describe the clinical characteristics of infants with late hemorrhagic disease of the newborn.
  • To highlight the association between lack of vitamin K prophylaxis and LHDN.
  • To emphasize the importance of vitamin K administration in preventing LHDN.

Main Methods:

  • Retrospective case series of 14 infants diagnosed with LHDN.
  • Review of clinical presentations, physical examination findings, and diagnostic tests (CT scans).
  • Analysis of vitamin K prophylaxis status and underlying health conditions.

Main Results:

  • 93% of infants presented with intracranial bleeding.
  • Common symptoms included seizures (71%) and vomiting (57%).
  • 57% of affected infants died, and 36% experienced neurological sequelae.

Conclusions:

  • Late hemorrhagic disease of the newborn results in high mortality and morbidity.
  • Lack of vitamin K prophylaxis is a significant risk factor.
  • Universal vitamin K prophylaxis for all newborns is essential for prevention.